Court Intrusion Into Science and Medicine—The Mifepristone Decisions-Reference-Cited by-同舟云学术

Court Intrusion Into Science and Medicine—The Mifepristone Decisions

Published:2023-05-23 Issue:20 Volume:329 Page:1735
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Aaron Daniel G.¹²,Brown Teneille R.³,Sinha Michael S.⁴

Affiliation:

1. S.J. Quinney College of Law at the University of Utah, Salt Lake City

2. US Court of Appeals for the Sixth Circuit, Louisville, Kentucky

3. Center for Law and the Biomedical Sciences, S.J. Quinney College of Law at the University of Utah, Salt Lake City

4. Center for Health Law Studies, Saint Louis University School of Law, St Louis, Missouri

Abstract

This Viewpoint discusses recent US court decisions on the availability of mifepristone, a drug used to terminate pregnancies, and how these conflicting court decisions affect the scientific process and decision-making of the US Food and Drug Administration.

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2804473/jama_aaron_2023_vp_230054_1684251816.23404.pdf

Reference10 articles.

1. Abortion safety and use with normally prescribed mifepristone in Canada.;Schummers;N Engl J Med,2022

2. Judicial review of public health powers since the start of the COVID-19 pandemic.;Parmet;Am J Public Health,2023

3. The end of Roe v Wade and new legal frontiers on the constitutional right to abortion.;Cohen;JAMA,2022

4. SARS-CoV-2 laboratory-developed tests: integrity restored.;Adashi;JAMA,2022

5. Tobacco reborn: the rise of e-cigarettes and regulatory approaches.;Aaron;Lewis Clark Law Rev,2021

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Firearm Policy in the Hospital Setting—Recognizing Health Care as a “Sensitive Place”;JAMA;2024-08-27

2. Medicare Advantage Under Fire: Public Criticism and Implications;Journal of General Internal Medicine;2024-06-26

3. US Supreme Court Limits on the Power of US Health Agencies;JAMA;2024-05-07

4. The FDA in the Crosshairs—Science, Politics, and Abortion;JAMA;2024-04-16

5. Consumer Protection, Agencies, and the Supreme Court;JAMA Health Forum;2024-04-05